ARCT Q1 2022 Earnings — Arcturus Therapeutics Holdings Inc. Revenue & Financial Results | Market Cap Arena

ARCTArcturus Therapeutics Holdings Inc.

$217M

Q1 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$5M+146.5% YoY

Gross Profit

-$40M-756.1% margin

Operating Income

-$50M-960.7% margin

Net Income

-$51M-975.8% margin

EPS (Diluted)

$-1.97

QoQ Revenue Growth

-9.5%

Cash Flow

Operating Cash Flow

-$49M

Free Cash Flow

-$51M

Stock-Based Comp.

$7M

Balance Sheet

Total Assets

$342M

Total Liabilities

$157M

Stockholders' Equity

$185M

Cash & Equivalents

$320M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$5M	$2M	+146.5%
Gross Profit	-$40M	-$48M	+17.3%
Operating Income	-$50M	-$58M	+12.6%
Net Income	-$51M	-$56M	+9.2%